Recent Advances in Diagnostic and Therapeutic Approaches for Breast Cancer: A Comprehensive Review.
Breast cancer
biomarkers
diagnosis
genes
omics
therapy.
Journal
Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487
Informations de publication
Date de publication:
2021
2021
Historique:
received:
11
09
2020
accepted:
22
01
2021
pubmed:
4
3
2021
medline:
26
10
2021
entrez:
3
3
2021
Statut:
ppublish
Résumé
A silent monster, breast cancer, is a challenging medical task for researchers. Breast cancer is a leading cause of death in women with respect to other cancers. A case of breast cancer is diagnosed among women every 19 seconds, and every 74 seconds, a woman dies of breast cancer somewhere in the world. Several risk factors, such as genetic and environmental factors, favor breast cancer development. This review tends to provide deep insights regarding the genetics of breast cancer along with multiple diagnostic and therapeutic approaches as problem-solving negotiators to prevent the progression of breast cancer. This assembled data mainly aims to discuss omics-based approaches to provide enthralling diagnostic biomarkers and emerging novel therapies to combat breast cancer. This review article intends to pave a new path for the discovery of effective treatment options.
Identifiants
pubmed: 33655849
pii: CPD-EPUB-114711
doi: 10.2174/1381612827666210303141416
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2344-2365Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.